Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Resource Type

CF Research News

Authors

Kopp BT, Fitch J, Jaramillo L, Shrestha CL, Robledo-Avila F, Zhang S, Palacios S, Woodley F, Hayes D Jr, Partida-Sanchez S, Ramilo O, White P., Meijas A.

References

J Cyst Fibros. 2019 Aug 29. pii: S1569-1993(19)30868-9. doi: 10.1016/j.jcf.2019.08.021. 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR [3]
RNA-seq [4]
Transcriptomics [5]

Date

Thursday, August 29, 2019

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/whole-blood-transcriptomic-responses-lumacaftorivacaftor-therapy

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00002R3_FINAL_Kopp_150919.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Whole-Blood%20Transcriptomic%20Responses%20to%20Lumacaftor/Ivacaftor%20Therapy%20in%20Cystic%20Fibrosis [3] https://www.ecfs.eu/research-article-keywords/cftr [4] https://www.ecfs.eu/research-article-keywords/rna-seq [5] https://www.ecfs.eu/research-article-keywords/transcriptomics [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines